Research programme: autoimmune disorders - Neose/Harvard University
Alternative Names: Autoimmune disorders research programme - Neose/Harvard UniversityLatest Information Update: 09 Sep 2003
At a glance
- Originator Harvard University; Neose Technologies
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 09 Sep 2003 Discontinued - Preclinical for Autoimmune disorders in USA (unspecified route)
- 20 Jun 2001 Preclinical development for Autoimmune disorders in USA (Unknown route)